Vanguard Group Inc Glaukos Corp Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Glaukos Corp stock. As of the latest transaction made, Vanguard Group Inc holds 5,965,115 shares of GKOS stock, worth $525 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,965,115
Previous 5,974,971 0.16%
Holding current value
$525 Million
Previous $896 Million 34.47%
% of portfolio
0.01%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$96.6 - $161.22 $952,089 - $1.59 Million
-9,856 Reduced 0.16%
5,965,115 $587 Million
Q4 2024

Feb 11, 2025
BUY
$126.42 - $152.67 $12.9 Million - $15.5 Million
101,838 Added 1.73%
5,974,971 $896 Million
Q3 2024

Nov 13, 2024
BUY
$113.62 - $135.39 $47.8 Million - $56.9 Million
420,376 Added 7.71%
5,873,133 $765 Million
Q2 2024

Aug 13, 2024
BUY
$89.48 - $118.35 $12.9 Million - $17 Million
143,860 Added 2.71%
5,452,757 $645 Million
Q1 2024

May 10, 2024
BUY
$76.4 - $96.33 $5.51 Million - $6.95 Million
72,159 Added 1.38%
5,308,897 $501 Million
Q4 2023

Feb 14, 2024
SELL
$59.53 - $85.11 $195,198 - $279,075
-3,279 Reduced 0.06%
5,236,738 $416 Million
Q3 2023

Nov 14, 2023
SELL
$69.23 - $79.09 $1.32 Million - $1.51 Million
-19,090 Reduced 0.36%
5,240,017 $394 Million
Q2 2023

Aug 14, 2023
SELL
$45.44 - $71.21 $2.08 Million - $3.26 Million
-45,840 Reduced 0.86%
5,259,107 $375 Million
Q1 2023

May 15, 2023
SELL
$43.88 - $52.48 $1.94 Million - $2.32 Million
-44,278 Reduced 0.83%
5,304,947 $266 Million
Q4 2022

Feb 10, 2023
SELL
$40.82 - $57.75 $1.29 Million - $1.82 Million
-31,495 Reduced 0.59%
5,349,225 $234 Million
Q3 2022

Nov 14, 2022
BUY
$46.84 - $58.49 $1.1 Million - $1.37 Million
23,473 Added 0.44%
5,380,720 $286 Million
Q2 2022

Aug 12, 2022
BUY
$34.86 - $63.77 $4.93 Million - $9.02 Million
141,482 Added 2.71%
5,357,247 $243 Million
Q1 2022

May 13, 2022
BUY
$44.33 - $57.82 $4.4 Million - $5.73 Million
99,170 Added 1.94%
5,215,765 $302 Million
Q4 2021

Feb 14, 2022
BUY
$40.27 - $56.99 $7.87 Million - $11.1 Million
195,364 Added 3.97%
5,116,595 $227 Million
Q3 2021

Nov 12, 2021
BUY
$47.43 - $84.23 $5.27 Million - $9.36 Million
111,178 Added 2.31%
4,921,231 $237 Million
Q2 2021

Aug 13, 2021
BUY
$73.06 - $97.7 $351 Million - $470 Million
4,810,053 New
4,810,053 $408 Million

Others Institutions Holding GKOS

# of Institutions
356
Shares Held
51M
Call Options Held
252K
Put Options Held
771K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.19B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email